Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Am J Psychiatry. 2001 Jun;158(6):931-7.

Impact of clozapine on completed suicide.

Author information

  • 1Psychiatry Service-116A, VA Connecticut Healthcare System, West Haven Campus, 950 Campbell Ave., West Haven, CT 06516, USA. michael.sernyak@yale.edu

Abstract

OBJECTIVE:

Clozapine has been found to be superior to typical neuroleptics in ameliorating the symptoms of refractory schizophrenia. This study evaluated clozapine's effect on the rate of death due to suicide.

METHOD:

All patients over a 4-year period who initiated treatment with clozapine while hospitalized within the Department of Veterans Affairs (VA) system (N=1,415) were matched with a schizophrenic control group (N=2,830) by propensity scoring-a widely accepted statistical method that has been used relatively little in psychiatric research. Centralized VA databases and a national death registry were used to identify all deaths within the two groups, along with listed causes, for the 3 years after discharge.

RESULTS:

Veterans exposed to clozapine while inpatients were significantly less likely to die during the follow-up period than those in the control group, but this was entirely attributable to the much lower rate of death due to respiratory disorders in the clozapine group. There were no significant differences in rates of suicide or accidental death.

CONCLUSIONS:

These results fail to support the hypothesis that clozapine treatment is associated with significantly fewer deaths due to suicide.

Comment in

  • Clozapine and suicide. [Am J Psychiatry. 2002]
  • Clozapine and suicide. [Am J Psychiatry. 2002]
PMID:
11384902
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Write to the Help Desk